Rationale and Study Design of the Withdrawal of Spironolactone for Heart Failure with Improved Left Ventricular Ejection Fraction

It is unclear if guideline-directed medical therapy (GDMT) should be maintained in patients who have heart failure (HF) with improved ejection fraction (HFiEF). Of the medications recommended for HF, mineralocorticoid receptor antagonist (MRA) is associated with heterogeneous results and considerabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Hyun, Junho, Lee, Sang Eun, Lee, Seung-Ah, Hong, Jung Ae, Kim, Min-Seok, Kim, Jae-Joong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Heart Failure 2021
Materias:
Trial Design
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536720/
https://www.ncbi.nlm.nih.gov/pubmed/36263115
http://dx.doi.org/10.36628/ijhf.2020.0044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536720/
https://www.ncbi.nlm.nih.gov/pubmed/36263115
http://dx.doi.org/10.36628/ijhf.2020.0044

Ejemplares similares